Adam Spice - 26 May 2023 Form 4 Insider Report for Rocket Lab USA, Inc. (RKLB)

Role: Chief Financial Officer
Signature: /s/ Arjun Kampani as Attorney-in-Fact for Adam Spice
Issuer symbol: RKLB
Transactions as of: 26 May 2023
Transactions value $: -$299,353
Form type: 4
Date filed: 31 May 2023, 18:57
Previous filing: 13 Mar 2023
Next filing: 29 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RKLB	Common Stock	Sale	-$299K	-66.6K	-3.95%	$4.50	1.62M	26 May 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person.
F2	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.39 to $4.515, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Content

Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.39 to $4.515, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.